Skip to main content
. 2024 Aug 7;45:101010. doi: 10.1016/j.lanepe.2024.101010

Table 1.

Patients characteristics, according to main underlying disease.

All n = 550 Haematological malignancy n = 358 (%) Burns n = 29 (%) Trauma n = 44 (%) Solid Organ Transplant n = 36 (%) Diabetes n = 41 (%) Other n = 42 (%) p (overall)
Mean age (year) 55.32 56.0 48.4 52.1 56.1 61.6 50.5 0.04
Male 361/550 (65.6) 220/358 (61.5) 20/29 (69.0) 33/44 (75.0) 27/36 (75.0) 33/40 (80.8) 28/42 (66.7) 0.11
ICU at diagnosis 182/550 (33.4) 79/358 (22.1) 28/29 (96.6) 15/44 (34.1) 15/36 (41.7) 16/41 (39.0) 19/42 (45.2) <0.001
Acute leukaemia 222/550 (40.4) 222/358 (62.0)
Lymphoma 49/550 (8.9) 49/358 (13.7)
Case classification
 Proven 207/550 (37.7) 115/358 (32.1) 11/29 (37.9) 22/44 (50.0) 17/36 (47.2) 23/41 (56.1) 19/42 (45.2)
 Probable 185/550 (34.1) 103/358 (28.7) 14/29 (48.3) 21/44 (47.7) 18/36 (50.0) 17/41 (41.5) 12/42 (28.6) 0.01
 Putative 158/550 (28.1) 140/358 (39.1) 4/29 (13.8) 1/44 (2.3) 1/36 (2.8) 1/41 (2.4) 11/42 (26.2)
Localisation
 Lung (localized) 288/550 (52.4) 229/358 (64.0) 0 2/44 (4.5) 22/36 (61.1) 14/41 (34.1) 21/42 (50.0) <0.001
 Rhino-orbito-cerebral (localized) 80/550 (14.5) 44/358 (12.3) 0 3/44 (6.8) 7/36 (19.4) 19/41 (46.4) 7/42 (16.7)
 Cutaneo-articular (localized) 94/550 (17.1) 19/358 (5.3) 26/29 (89.7) 38/44 (86.4) 3/36 (8.3) 4/41 (9.8) 4/42 (9.5)
 Other (localized) 27/550 (4.9) 17/358 (4.7) 0 1/44 (2.3) 3/36 (8.3) 1/41 (2.5) 5/42 (11.9)
 Disseminated 61/550 (11.1) 49/358 (13.7) 3/29 (10.3) 0 1/36 (2.7) 3/41 (7.3) 5/42 (11.9)
Fungal species
 Rhizopus arrhizus 67/316 (21.2) 32/161 (19.9) 0 2/42 (4.8) 9/29 (31.0) 18/31 (58.1) 6/29 (20.7)
 Rhizopus microsporus 43/316 (13.6) 26/161 (16.1) 1/24 (4.2) 2/42 (4.8) 6/29 (20.7) 4/31 (12.9) 4/29 (13.8) <0.001
 Lichtheimia corymbifera 42/316 (13.3) 27//161 (16.7) 3/24 (12.5) 5/42 (11.9) 3/29 (10.3) 0 4/29 (13.8)
 Mucor circinelloides 42/316 (13.3) 5/161 (3.1) 15/24 (62.5) 17/42 (40.5) 2/29 (6.9) 0 3/29 (10.3)
 Rhizomucor pusillus 38/316 (12.0) 33/161 (20.5) 0 1/42 (23.8) 1/29 (3.4) 0 3/29 (10.3)
 Lichtheimia ramosa 34/316 (10.8) 13/161 (8.1) 5/24 (20.8) 11/42 (26.2) 1/29 (3.4) 2/31 (6.4) 2/29 (6.9)
 Others 50/316 (15.8) 25/161 (15.5) 0 4/42 (9.5) 7/29 (24.1) 7/31 (22.6) 7/29 (24.1)
Fungal coinfection 132/550 (24.0) 80/358 (22.3) 8/29 (27.6) 20/44 (45.5) 9/36 (25.0) 5/41 (12.2) 10/42 (23.8) 0.01
Positive PCRa 379/550 (68.9) 275/358 (76.8) 19/29 (65.5) 15/44 (34.1) 17/36 (47.2) 21/41 (51.2) 32/42 (76.2)
 Positive PCR on serum 278/550 (50.5) 221/358 (61.7) 19/29 (65.5) 4/44 (9.1) 8/36 (22.2) 10/41 (24.4) 16/42 (38.1) <0.001
 Positive PCR on pulmonary samples 131/550 (23.8) 104/358 (29.1) 0 0 8/36 (22.2) 5/41 (12.2) 14/42 (33.3) <0.001
Diagnosis after 2015 451/550 (82.0) 299/358 (83.5) 18/29 (62.1) 37/44 (84.1) 32/36 (88.9) 29/41 (70.7) 36/42 (85.7) 0.051
Surgical treatment 166/441 (37.6) 58/276 (21.0) 27/29 (93.1) 40/41 (97.6) 11/29 (37.9) 19/34 (55.9) 11/32 (34.4) <0.001
First-line therapy
 Liposomal amphotericin B (all) 413/550 (75.1) 267/358 (74.6) 24/29 (82.8) 39/44 (88.6) 26/36 (72.2) 32/41 (78.0) 27/42 (64.2)
 Liposomal amphotericin B (monotherapy) 318/550 (57.8) 193/358 (53.9) 19/29 (65.5) 35/44 (79.5) 21/36 (58.3) 27/41 (65.9) 23/42 (54.8) <0.01
 Isavuconazole (monotherapy) 36/550 (6.5) 26/358 (7.3) 0 0 2/36 (5.6) 3/41 (7.3) 5/42 (11.9)
 Posaconazole (monotherapy) 11/550 (2.0) 8/358 (2.2) 0 1/44 (2.3) 1/36 (2.8) 1/41 (2.5) 0
Death before day 90 276/495 (55.8) 203/317 (64.0) 10/27 (37.0) 8/43 (18.6) 19/34 (55.9) 16/37 (43.2) 20/37 (54.1) <0.001

ICU: Intensive Care Unit. Denominator represents the number of patients for whom the information was available.

a

All samples included. Denominators for PCR data are 550 despite the fact that not all patients had PCR screening.